The Nanostim is implanted through the femoral vein with a steerable catheter instead of leads, eliminating the need for a surgical pocket and surgical scars, according to the news release. The pacemaker is fully retrievable, meaning surgeons can reposition it during a procedure or later retrieve it if necessary. Additionally, the leadless pacemaker is less than ten percent the size of a traditional pacemaker, according to the news release.
“The small size of the device and lack of a surgical pocket, coupled with the exclusion of a lead, improves patient comfort and can reduce complications, including device pocket-related infection and lead failure,” says the news release, adding patients may not be so restricted in their activities, thereby improving their quality of life.
The Nanostim leadless pacemaker received CE Mark approval and is available in select European markets. It is not available in the U.S.
More Articles on Medical Devices:
Clinical Effectiveness More Important Than Technological Accuracy When Selecting Speech-Recognition Software
10 Biggest Technological Advancements for Healthcare in the Last Decade
Medical Imaging Equipment Market to Reach $35B by 2019
